首页> 外文OA文献 >375 EFFICACY AND SAFETY OF TWICE-DAILY DOSING OF CONTROLLED-RELEASE HYDROCODONE AND ACETAMINOPHEN TABLETS FOR MODERATE TO SEVERE OSTEOARTHRITIS PAIN: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-COONTROLLED STUDY

【2h】

375 EFFICACY AND SAFETY OF TWICE-DAILY DOSING OF CONTROLLED-RELEASE HYDROCODONE AND ACETAMINOPHEN TABLETS FOR MODERATE TO SEVERE OSTEOARTHRITIS PAIN: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-COONTROLLED STUDY

机译：375次中度至重度骨关节炎疼痛的可控释氢可酮和醋胺酮片剂两次剂量的安全性和安全性：第2阶段，随机，双盲，局部麻醉研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Gilderman L.; Box J.; Rankin B.; Podolsky G.; Morris D.; Thomas J.; Lockhart E.; Jain R.;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. 羟考酮/纳洛酮控释片与羟考酮控释片治疗韩国癌性疼痛患者的疗效及安全性的随机对照研究 [J] . Kyung-He Lee, Min Kyoung Kim, Yong Sang Hong, 癌症（英文版） . 2018,第005期
2. Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study. [J] . Ridgway D, Sopata M, Burneckis A, Journal of pain and symptom management. . 2010,第4期

机译：在癌症疼痛患者中，每天一次新型口服缓释吗啡片与标准控释吗啡片剂一日两次的临床疗效和安全性：一项随机，双盲，探索性交叉研究。
3. Clinical Efficacy and Safety of Once-Daily Dosing of a Novel, Prolonged-Release Oral Morphine Tablet Compared With Twice-Daily Dosing of a Standard Controlled-Release Morphine Tablet in Patients With Cancer Pain: A Randomized, Double-Blind, Exploratory Cr [J] . Derry Ridgway, Maciej Sopata, Arvydas Burneckis, Journal of pain and symptom management. . 2010,第4期

机译：每日两次新型，延长剂量口服吗啡片与标准控释吗啡片剂两次每日给药对癌痛的临床疗效和安全性：随机，双盲，探索性Cr
4. A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back pain [J] . Wen Warren, Sitar Steve, Lynch Shau Yu, Expert opinion on pharmacotherapy . 2015,第11期

机译：多中心，随机，双盲，安慰剂对照试验，用于评估单一实体，一次每日氢化酮片剂的疗效和安全性，患者不受控制的中度至重度慢性低腰疼痛
5. A Phase I, Double-Blind, Randomized, Dose Escalating Crossover Study ofan Oral Formulation of Human Growth Hormone in Healthy Male Volunteers [C] . Steven M. Dinh, Puchun Liu, Ehud Arbit, Controlled Release Society annual meeting . 2004

机译：健康男性志愿者中人类生长激素口服制剂的I期，双盲，随机，剂量递增交叉研究
6. A dose finding method in joint modeling of efficacy and safety endpoints in phase II studies - an extension of the MCP-MOD method. [D] . Tao, Aiyang. 2010

机译：II期研究中疗效和安全性终点联合建模中的一种剂量寻找方法-MCP-MOD方法的扩展。
7. A randomized double-blind active-controlled double-dummy parallel-group study to determine the safety and efficacy of oxycodonealoxone prolonged-release tablets in patients with moderate/severe chronic cancer pain [O] . Sam H Ahmedzai, Friedemann Nauck, Gil Bar-Sela, -1

机译：一项随机双盲主动控制双模拟平行组研究以确定羟考酮/纳洛酮缓释片在中度/重度慢性癌症疼痛患者中的安全性和有效性
8. Efficacy, Safety, and Tolerability of Fulranumab as an Adjunctive Therapy in Patients With Inadequately Controlled, Moderate-to-Severe Chronic Low Back Pain: A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Dose-loading Phase II Study [O] . Sanga Panna, Polverejan Elena, Wang Steven, 2016

机译：控制性不佳，中度至重度慢性下腰痛患者的Fulranumab辅助治疗的疗效，安全性和耐受性：一项随机，双盲，安慰剂对照，剂量范围，剂量负荷II期研究

375 EFFICACY AND SAFETY OF TWICE-DAILY DOSING OF CONTROLLED-RELEASE HYDROCODONE AND ACETAMINOPHEN TABLETS FOR MODERATE TO SEVERE OSTEOARTHRITIS PAIN: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-COONTROLLED STUDY

著录项

相似文献

相关主题

期刊订阅